Partnership Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-580
Closed -$134K 191
2024
Q2
$134K Sell
580
-5,742
-91% -$1.25M 0.1% 110
2024
Q1
$1.36M Sell
6,322
-157
-2% -$36.8K 0.96% 37
2023
Q4
$1.6M Buy
+6,479
New +$1.59M 1.2% 29

Other funds holding BIIB

Partnership Wealth Management's BIIB Position: Q3 2024 in Review

Partnership Wealth Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 580 shares — an estimated $134K sold.

Partnership Wealth Management first reported a position in BIIB in Q4 2023 and held it in 3 quarters. The position peaked at $1.6M in Q4 2023. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Partnership Wealth Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Partnership Wealth Management sold 580 Biogen shares in Q3 2024, an estimated $134K.
  • Partnership Wealth Management first reported a position in Biogen in Q4 2023 and held it in 3 quarters.
  • Partnership Wealth Management's Biogen position peaked at $1.6M in Q4 2023.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Partnership Wealth Management's 13F filing for Q3 2024, filed 8 Oct 2024.